Unknown

Dataset Information

0

Mesenchymal stem cell transplantation can restore lupus disease-associated miRNA expression and Th1/Th2 ratios in a murine model of SLE.


ABSTRACT: C3.MRL-Faslpr/J mice spontaneously develop high titers of anti-dsDNA, mild glomerular nephritis, and severe lymphoproliferation symptoms. This study aimed to compare the effects of long-term serial administration of human adipose tissue-derived mesenchymal stem cells (ASCs), and cyclophosphamide treatment in C3.MRL-Faslpr/J mice using a murine SLE model. C3.MRL-Faslpr/J mice were divided into saline (C), cyclophosphamide (Y), and ASC (H) treatment groups. Background-matched control C3H mice treated with saline (N) were also compared. The Y group showed the greatest improvement in disease parameters, but with damaged trabecular integrity. ASC transplantation reduced anti-dsDNA levels, glomerular C3 deposition and CD138 proportion significantly, without trabecular damage. Furthermore, both cyclophosphamide and ASC treatment significantly decreased the ratio of Th1/Th2 compared with the saline-treatment. The expression levels of miR-31-5p, miR-96-5p, miR-182-5p, miR-183-5p, and miR-379-5p were significantly higher, while those of miR150-5p were significantly lower in the C group than in the N group. The expression levels of miR-96-5p, miR-182-5p in the Y and H groups were significantly lower than in the C group. Thus, treatment with cyclophosphamide or ASC can change miRNAs and decrease miR-96-5p and miR-182-5p expression, as well as decreasing the CD138 proportion and the Th1/Th2 ratio, which might be involved in the therapeutic mechanism.

SUBMITTER: Choi EW 

PROVIDER: S-EPMC5141468 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesenchymal stem cell transplantation can restore lupus disease-associated miRNA expression and Th1/Th2 ratios in a murine model of SLE.

Choi Eun Wha EW   Lee MinJae M   Song Ji Woo JW   Shin Il Seob IS   Kim Sung Joo SJ  

Scientific reports 20161207


C3.MRL-Fas<sup>lpr</sup>/J mice spontaneously develop high titers of anti-dsDNA, mild glomerular nephritis, and severe lymphoproliferation symptoms. This study aimed to compare the effects of long-term serial administration of human adipose tissue-derived mesenchymal stem cells (ASCs), and cyclophosphamide treatment in C3.MRL-Fas<sup>lpr</sup>/J mice using a murine SLE model. C3.MRL-Fas<sup>lpr</sup>/J mice were divided into saline (C), cyclophosphamide (Y), and ASC (H) treatment groups. Backgro  ...[more]

Similar Datasets

| S-EPMC6761280 | biostudies-literature
| S-EPMC9271959 | biostudies-literature
| S-EPMC6886797 | biostudies-literature
2022-05-06 | E-MTAB-8823 | biostudies-arrayexpress
| S-EPMC5476698 | biostudies-literature
| S-EPMC1257534 | biostudies-literature
| S-EPMC3912696 | biostudies-literature
| S-EPMC5444015 | biostudies-literature
2015-09-16 | GSE72509 | GEO
2015-09-16 | E-GEOD-72509 | biostudies-arrayexpress